BSX

Q: What is the price of Boston Scientific (BSX) today?

The price of Boston Scientific (BSX) today is US$ 95,41, with a variation of 10.68% compared to the last year. The price of Boston Scientific (BSX) started the year trading around US$ 89,32 and today it is at US$ 95,41. Follow the real-time price chart, the historical price of Boston Scientific (BSX), and stock data from Ibovespa and international markets.

Q: When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not distribute dividends in the last year.

Q: Boston Scientific (BSX) is it worth it?

Currently, Boston Scientific (BSX) is priced at US$ 95,41, with a P/E of 50,82%, representing a deviation of 62,57% from its historical average P/E. In the last year, the stock showed a variation of 10.68% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 10,68%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Boston Scientific (BSX)?

Investing in stocks of Boston Scientific (BSX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Boston Scientific (BSX) yield today?

The yield of Boston Scientific (BSX) was -9,33% in the last month, 10,68% in the last year and 127,33% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Boston Scientific (BSX) today, the total investment would be US$ 9.541,00, based on the current price of US$ 95,41.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 10.559,98In 5 years: US$ 21.689,56In 10 years: 54.640,35It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Boston Scientific Corp.

Price

US$ 95,41

variation (12m)

10,68%

p/l

50,82

p/vp

6,36

DIVIDEND YIELD

0,00%

price BSX

BVMF

BSX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of BSX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-9,33%

3 months

-7,55%

1 year

10,68%

2 years

96,16%

5 years

127,33%

10 years

472,69%

real profitability

profitability minus inflation.

1 month

-9,33%

3 months

-7,89%

1 year

5,83%

2 years

79,04%

5 years

67,99%

10 years

242,88%

Indicators BSX

check out the fundamentals of Boston Scientific shares

P/E

50,82

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

7,45

Sector: 1,95 Industry: 2,78

P/BV

6,36

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

6,82%

Sector: -26,82% Industry: -52,06%

ROE

12,51%

Sector: -29,98% Industry: -40,51%

ROIC

8,72%

Sector: -411,56% Industry: -412,66%

NET MARGIN

14,65%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

67,99%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

18,68%

Sector: -23,36% Industry: -26,70%

P/EBITDA

29,04

Sector: 0,02 Industry: -2,09

P/EBIT

39,85

Sector: -1,26 Industry: -2,90

P/ASSET

3,47

Sector: 1,27 Industry: 1,41

BVPS

15,31

Sector: 3,73 Industry: 1,64

EPS

1,91

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,55

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

14,04%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Boston Scientific ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 95,41

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-73,12%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

BSX indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%
CNC	17,57	0,70	3,96%	0,00%	US$ 19,12 B	0,59%

comparison of BSX with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History BSX

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Boston Scientific

Boston Scientific Corp.

Average user rating I10

4.0 (33 people)

Estados Unidos

46 years

Foundation: 1979

1992

Year of debut on the stock exchange - 33 years

36.000

Employees

Additional Information

The Company Boston Scientific Corp. (Estados Unidos), is listed on NYSE with a market value of $ 144,03 Billions, having a net worth of $ 22,65 Billions.

With a total of 36.000 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 19,35 Billions, which generated a profit in the amount of $ 2,83 Billions.

As for its main indicators, the Company has a P/E ratio of 50,82, a P/BV ratio of 6,36 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BSX.

Market value

US$ 144,03 Billions

Net worth

US$ 22,65 Billions

US$ 22.653.000.000,00

Assets

US$ 41,56 Billions

US$ 41.559.000.000,00

Total Number of Shares

1,48 Billion

1.480.000.000

Average Daily Trading Volume

US$ 8,56 Milhões

US$ 8.563.214,00

Sector

Health

Industry

Medical Supplies and Equipment

BSX

BSX revenue and profits

BSX results

DRAG THE FRAME TO SEE MORE DATA

BSX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of Boston Scientific (BSX) today?

The price of Boston Scientific (BSX) today is US$ 95,41, with a variation of 10.68% compared to the last year. The price of Boston Scientific (BSX) started the year trading around US$ 89,32 and today it is at US$ 95,41. Follow the real-time price chart, the historical price of Boston Scientific (BSX), and stock data from Ibovespa and international markets.

When does Boston Scientific (BSX) pay dividends?

Boston Scientific (BSX) did not distribute dividends in the last year.

Boston Scientific (BSX) is it worth it?

Currently, Boston Scientific (BSX) is priced at US$ 95,41, with a P/E of 50,82%, representing a deviation of 62,57% from its historical average P/E. In the last year, the stock showed a variation of 10.68% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 10,68%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Boston Scientific (BSX)?

Investing in stocks of Boston Scientific (BSX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Boston Scientific (BSX) yield today?

The yield of Boston Scientific (BSX) was -9,33% in the last month, 10,68% in the last year and 127,33% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of Boston Scientific (BSX) today, the total investment would be US$ 9.541,00, based on the current price of US$ 95,41.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 10.559,98
In 5 years: US$ 21.689,56
In 10 years: 54.640,35

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BSX

Boston Scientific Corp.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of BSX

check out the fundamentals of Boston Scientific shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Boston Scientific

Boston Scientific Corp.

Estados Unidos

46 years

1992

36.000

Additional Information

PROFIT X PRICE BSX

BSX results

BSX cash flow

evolution of assets - BSX

BSX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions